Skip to main content
Tuberculosis in Tondo, Manila - Ezra Acayan
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
 
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.

Tuberculosis

Quick facts about tuberculosis

 
HIV/AIDS

Khayelitsha Activity Report 2001-2011: 10 Years of HIV/TB Care at Primary Health Care Level

Report 29 Jun 2011
 
Tuberculosis

Challenge and Urgency to scale up tuberculosis care

Speech 3 Jun 2011
 
Uzbekistan

Comprehensive TB care for all: The Karakalpakstan Experience

Report 2 May 2011
 
Tuberculosis

New TB test to detect more people who need DR-TB treatment

Press Release 24 Mar 2011
 
Cambodia

Improving TB care in Cambodia

Project Update 24 Mar 2011
 
MSF treats DR-TB cases
Tuberculosis

DR-TB drugs under the microscope

Report 23 Mar 2011
 
South Africa

Scaling up Diagnosis and Treatment of Drug-resistant Tuberculosis in Khayelitsha, South Africa

Report 11 Mar 2011
 
Tuberculosis

New TB test brings hope

Project Update 25 Feb 2011
 
Tuberculosis

Meet the first MSF patient to have recovered from XDR-TB

Project Update 23 Dec 2010
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB